2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

@article{Goff20142013AG,
  title={2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines},
  author={D. Goff and D. Lloyd‐Jones and G. Bennett and S. Coady and R. D'Agostino and R. Gibbons and P. Greenland and D. Lackland and D. Levy and C. O’Donnell and Jennifer G. Robinson and J. Schwartz and Susan T. Shero and Sidney C. Smith and P. Sorlie and N. Stone and P. Wilson},
  journal={Circulation},
  year={2014},
  volume={129},
  pages={S49–S73}
}
Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S50 The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular diseases (CVD); improve the management of people who have these diseases through professional education and research; and develop guidelines, standards, and policies that promote optimal patient care and cardiovascular health. Toward these objectives, the ACC and AHA have collaborated with… Expand

Paper Mentions

Observational Patient Registry Clinical Trial
The ultimate goal of this project is to develop a risk score to identify patients with vulnerable coronary atherosclerotic plaques, who are prone to suffer acute coronary syndrome… Expand
ConditionsAtherosclerosis, Cardiovascular Disease, Coronary Artery Disease
2013 ACC/AHA Cholesterol Guideline for Reducing Cardiovascular Risk: What is so Controversial?
TLDR
In November 2013, the American College of Cardiology and American Heart Association released a clinical practice guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease (ASCVD) risk in adults, developed from a rigorous systematic review of randomized, controlled trials and meta-analyses that evaluated ASCVD outcomes. Expand
Overview of 2013 American College of Cardiology/American Heart Association cholesterol guideline for reducing cardiovascular risk
TLDR
The 2013 ACC/AHA cholesterol recommendations focus on using the appropriate intensity of statin therapy in those most likely to experience a net ASCVD risk-reduction benefit, and recommend treatment to specific low density lipoprotein cholesterol (LDL-C) and nonhigh density cholesterol (non-HDL- C) treatment goals. Expand
Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease.
TLDR
Whether applying the ACC/AHA guidelines has similar public health consequences as applying the ESC guidelines on management of cardiovascular (CV) risk in primary prevention is investigated. Expand
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
TLDR
The Task Force recognizes the need for objective, independent Evidence Review Committees that include methodologists, epidemiologists, clinicians, and biostatisticians who systematically survey, abstract, and assess the evidence to address systematic review questions posed in the PICOTS format. Expand
New American Heart Association/American College of Cardiology guidelines on cardiovascular risk: when will fitness get the recognition it deserves?
  • J. Myers
  • Medicine
  • Mayo Clinic proceedings
  • 2014
TLDR
The new guidelines recommend statins for people with a lower risk of cardiovascular disease (CVD) than in previous guidelines and for those at risk for stroke and eliminate the earlier criterion that apatient’s low-density lipoprotein cholesterol must be low. Expand
Similarities and Differences Between the ACC/AHA and ESH/ESC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.
TLDR
The ACC/AHA guideline extended the previous Joint National Committee Report 7 (JNC 7) to include updated information from clinical trials and meta-analyses on BP level and cardiovascular risk. Expand
The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cholesterol management and for cardiovascular risk stratification: A reappraisal
TLDR
A critical review of these guidelines, along with the related document on CV risk stratification, is warranted before the authors embark on the task to incorporate them in to clinical practice. Expand
Concepts and Controversies: The 2013 American College of Cardiology/American Heart Association Risk Assessment and Cholesterol Treatment Guidelines
TLDR
The core concepts of the guidelines are highlighted, core concepts that rest on widespread consensus, controversial aspects are discussed, and a potential middle ground for clinicians and patients struggling with how to proceed in the midst of the controversy are suggested. Expand
A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps.
TLDR
The goal of the Mayo Clinic Task Force in the assessment, interpretation, and expansion of the ACC/AHA cholesterol treatment guideline is to address gaps in information and some of the controversial aspects of the newly released cholesterol management guideline using additional sources of evidence and expert opinion as needed to guide clinicians on key aspects of ASCVD risk reduction. Expand
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines (guidelines) with recommendations toExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 343 REFERENCES
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiova
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention ofExpand
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
TLDR
The goals of the American College of Cardiology and the American Heart Association are to prevent cardiovascular diseases (CVDs) and improve the management of these diseases. Expand
AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention
TLDR
Over the past decade, there has been an increasing awareness that the quality of medical care in the United States is highly variable and recognition of the magnitude of the gap between the Care that is delivered and the care that ought to be provided has stimulated interest in the development of new treatments. Expand
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
It is essential that the medical profession play a central role in critically evaluating the evidence related to drugs, devices, and procedures for the detection, management, or prevention ofExpand
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Alice K. Jacobs, MD, FACC, FAHA, Chair, 2009–2011 Sidney C. Smith, Jr, MD, FACC, FAHA, Immediate Past Chair, 2006–2008 [⁎⁎⁎][1] Jeffrey L. Anderson, MD, FACC, FAHA, Chair-Elect Nancy Albert,Expand
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S2 The goals of the …
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
TLDR
The development of the present guideline involved a process of partial adaptation of other guideline statements and reports and supplemental literature searches, which confirmed that in patients with atherosclerotic vascular disease, comprehensive risk factor management reduces risk as assessed by a variety of outcomes. Expand
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
TLDR
This statement provides an overview of evidence and arguments supporting the inclusion of patients with stroke, and atherosclerotic stroke in particular, among those considered to be at high absolute risk of cardiovascular disease and theclusion of stroke as part of the outcome cluster in risk prediction instruments for vascular disease. Expand
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am
TLDR
This update provides a reassessment of clinical scenarios the writing group felt to be affected by significant changes in the medical literature or gaps from prior criteria, and felt that based on recent studies, coronary artery bypass grafting remains an appropriate method of revascularization for patients with high burden of coronary artery disease. Expand
The next steps in developing clinical practice guidelines for prevention.
TLDR
The American Heart Association and the American College of Cardiology are asked to assume the governance and management of these prevention guidelines and to ensure their completion and dissemination to the public. Expand
...
1
2
3
4
5
...